Institute for Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Germany.
Cancer Treat Rev. 2010 Jun;36(4):277-85. doi: 10.1016/j.ctrv.2010.02.003. Epub 2010 Mar 15.
The present contribution reports childhood cancer incidence and survival rates as well as time trends and geographical variation. The report is based on the databases of population-based cancer registries which joined forces in cooperative projects such as Automated Childhood Cancer Information System (ACCIS) and EUROCARE. According to these data, which refer to the International Classification of Childhood Cancer, leukemias, at 34%, brain tumors, at 23%, and lymphomas, at 12%, represent the largest diagnostic groups among the under 15-year-olds. The most frequent single diagnoses are: acute lymphoblastic leukemia, astrocytoma, neuroblastoma, non-Hodgkin lymphoma, and nephroblastoma. There is considerable variation between countries. Incidence rates range from 130 (British Isles) to 160 cases (Scandinavian countries) per million children. Incidence rates have shown an increase over time since the mid of the last century. In Europe, the yearly increase averages 1.1% for the 1978-1997 period and ranges from 0.6% for the leukemias to 1.8% for soft-tissue sarcomas. The probability of survival has risen considerably over the past decades, with the EUROCARE data showing an improvement of the relative risk of death by 8% when comparing the 2000-2002 time span to the 1995-1999 period. Regarding the years 1995-2002, the data show an overall 5-year survival probability of 81% for Europe and similar values for the USA. The data presented here describe the cancer situation with a specific, European focus. They are drawn from population-based cancer registries that ensure excellent data quality, and as a consequence represent the most valid European population-based data existing at present. It is also apparent that not all countries have data available from nationwide childhood cancer registries, a situation which warrants further improvement.
本报告介绍了儿童癌症的发病率和生存率,以及时间趋势和地域差异。本报告基于参加合作项目(如自动化儿童癌症信息系统(ACCIS)和 EUROCARE)的人口癌症登记数据库。根据这些数据,参考国际儿童癌症分类,白血病占 34%,脑肿瘤占 23%,淋巴瘤占 12%,是 15 岁以下儿童最大的诊断群体。最常见的单一诊断是:急性淋巴细胞白血病、星形细胞瘤、神经母细胞瘤、非霍奇金淋巴瘤和肾母细胞瘤。各国之间存在相当大的差异。发病率从每百万儿童 130 例(不列颠群岛)到 160 例(斯堪的纳维亚国家)不等。自上个世纪中叶以来,发病率呈上升趋势。在欧洲,1978-1997 年期间,每年的增长率平均为 1.1%,从白血病的 0.6%到软组织肉瘤的 1.8%不等。在过去几十年中,生存率有了显著提高,EUROCARE 数据显示,与 1995-1999 年期间相比,2000-2002 年期间死亡相对风险降低了 8%。就 1995-2002 年而言,数据显示欧洲的整体 5 年生存率为 81%,美国也有类似的值。本报告介绍了具有特定欧洲重点的癌症情况。它们来自人口癌症登记处,这些登记处确保了数据的高质量,因此代表了目前存在的最有效的欧洲基于人口的现有数据。很明显,并非所有国家都有全国性儿童癌症登记处的数据,这种情况需要进一步改善。